We are live on
!
Find out more
First Trust Advisors Portfolio holdings
AUM
$170B
1-Year Est. Return
46.21%
This Fund
S&P 500
This Quarter
Est. Return
+6.72%
1 Year Est. Return
+46.21%
3 Year Est. Return
+117.8%
5 Year Est. Return
+135.17%
10 Year Est. Return
+586.77%
AUM
$34B
AUM Growth
+$4.4B
(+15%)
Cap. Flow
+$3.11B
Cap. Flow
% of AUM
9.14%
Top 10 Holdings %
Top 10 Hldgs %
11.75%
Holding
2,403
New
160
Increased
1,020
Reduced
1,025
Closed
188
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
First Trust NYSE Arca Biotechnology Index Fund
FBT
|
+$308M |
| 2 |
First Trust Health Care AlphaDEX Fund
FXH
|
+$249M |
| 3 |
First Trust Consumer Staples AlphaDEX Fund
FXG
|
+$221M |
| 4 |
First Trust Dow Jones Internet Index Fund ETF
FDN
|
+$217M |
| 5 |
First Trust Consumer Discretionary AlphaDEX Fund
FXD
|
+$209M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CBST
CUBIST PHARMACEUTICALS INC
CBST
|
+$96.7M |
| 2 |
NPSP
NPS PHARMACEUTICALS INC
NPSP
|
+$85M |
| 3 |
AGN
Allergan Inc
AGN
|
+$64.4M |
| 4 |
MJN
Mead Johnson Nutrition Company
MJN
|
+$58.1M |
| 5 |
PepsiCo
PEP
|
+$54.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 21.89% |
| 2 | Miscellaneous | 13.15% |
| 3 | Consumer Discretionary | 11.23% |
| 4 | Technology | 11.05% |
| 5 | Consumer Staples | 8.32% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SNV
1626
DELISTED
Synovus
SNV
| $1.39M | ﹤0.01% |
49,653
-40,140
| -45% | -$1.09M |
|
|
AIRM
1627
DELISTED
Air Methods Corp
AIRM
| $1.39M | ﹤0.01% |
29,811
-15,404
| -34% | -$705K |
|
1628
Veeco
VECO
$2.79B
| $1.39M | ﹤0.01% |
45,396
-11,550
| -20% | -$361K |
|
1629
Simmons First National
SFNC
$3.35B
| $1.39M | ﹤0.01% |
60,916
+20,674
| +51% | +$421K |
|
1630
NewMarket
NEU
$7.98B
| $1.38M | ﹤0.01% |
2,896
-11,914
| -80% | -$5.38M |
|
1631
COPT Defense Properties
CDP
$4.02B
| $1.38M | ﹤0.01% |
47,081
-5,822
| -11% | -$172K |
|
|
EFOR
1632
Everforth Inc
EFOR
$1.27B
| $1.37M | ﹤0.01% |
+35,762
| New | +$1.3M |
|
1633
MarketAxess Holdings
MKTX
$5.75B
| $1.37M | ﹤0.01% |
16,539
-9,766
| -37% | -$773K |
|
1634
West Pharmaceutical
WST
$23.8B
| $1.37M | ﹤0.01% |
22,756
-13,132
| -37% | -$700K |
|
|
SHLM
1635
DELISTED
Schulman (A.) Inc
SHLM
| $1.37M | ﹤0.01% |
28,414
-2,498
| -8% | -$98.7K |
|
|
WSTC
1636
DELISTED
West Corporation
WSTC
| $1.37M | ﹤0.01% |
40,602
-50,652
| -56% | -$1.68M |
|
1637
ACI Worldwide
ACIW
$5.25B
| $1.37M | ﹤0.01% |
63,191
-117,475
| -65% | -$2.33M |
|
1638
Kemper
KMPR
$1.57B
| $1.36M | ﹤0.01% |
34,985
-108,614
| -76% | -$4.01M |
|
1639
Littelfuse
LFUS
$10.7B
| $1.36M | ﹤0.01% |
13,680
+1,145
| +9% | +$112K |
|
|
THQ
1640
abrdn Healthcare Opportunities Fund
THQ
$806M
| $1.35M | ﹤0.01% |
65,631
+4,576
| +7% | +$92.3K |
|
1641
Integra LifeSciences
IART
$1.26B
| $1.35M | ﹤0.01% |
53,524
-45,514
| -46% | -$1.08M |
|
1642
ICU Medical
ICUI
$4.02B
| $1.35M | ﹤0.01% |
14,479
-2,026
| -12% | -$177K |
|
1643
Medifast
MED
$136M
| $1.35M | ﹤0.01% |
44,936
+6,788
| +18% | +$215K |
|
|
SNCR
1644
DELISTED
Synchronoss Technologies
SNCR
| $1.35M | ﹤0.01% |
3,151
-2,946
| -48% | -$1.16M |
|
1645
Columbia Banking Systems
COLB
$8.56B
| $1.34M | ﹤0.01% |
46,392
-19,659
| -30% | -$539K |
|
|
CLVS
1646
DELISTED
Clovis Oncology, Inc.
CLVS
| $1.34M | ﹤0.01% |
+18,065
| New | +$1.28M |
|
1647
Hawkins
HWKN
$2.65B
| $1.34M | ﹤0.01% |
70,398
-28,236
| -29% | -$551K |
|
1648
Jefferies Financial Group
JEF
$12.8B
| $1.34M | ﹤0.01% |
+67,028
| New | +$1.39M |
|
1649
BlackRock Science and Technology Trust
BST
$1.76B
| $1.33M | ﹤0.01% |
+75,745
| New | +$1.34M |
|
1650
Monro
MNRO
$391M
| $1.33M | ﹤0.01% |
20,528
+10,229
| +99% | +$626K |
|
Similar funds
First Trust Advisors's Q1 2015 Portfolio in Review
As of Q1 2015, First Trust Advisors held 2,403 positions worth $34B, up 15% from $29.6B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
First Trust Advisors deployed $3.11B of net new capital in Q1 2015, opening 160 new positions and adding to 1,020 existing holdings. Its largest new stake was Novavax: 705,902 shares worth $117M.
By sector, the portfolio is most concentrated in Healthcare at 22% of assets, up from 18% a quarter earlier, followed by Miscellaneous and Consumer Discretionary.
On the sell side, the largest reduction was PepsiCo, an estimated $54.5M trimmed.
- First Trust Advisors's largest Q1 2015 buy was Novavax: 705,902 shares worth $117M.
- First Trust Advisors added most to First Trust NYSE Arca Biotechnology Index Fund in Q1 2015, an estimated $308M increase.
- First Trust Advisors's biggest Q1 2015 reduction was PepsiCo, cutting an estimated $54.5M.
- First Trust Advisors fully exited CUBIST PHARMACEUTICALS INC in Q1 2015, selling an estimated $96.7M.
- First Trust Advisors's ten largest holdings make up 12% of its $34B portfolio in Q1 2015.
- First Trust Advisors opened 160 new positions and closed 188 in Q1 2015.
- First Trust Advisors's portfolio value rose 15% quarter-over-quarter to $34B.
Based on First Trust Advisors's 13F filing for Q1 2015, filed 4 May 2015.